V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010157 | 270005958 | 1.65 | 93.2 | Disease modification (D) | 2015-11-18 | 2015-11-20 | CHOP - 21 days | 2 | N | 270023358 | NOT MATCHED |
| 270010158 | 270005959 | 1.79 | 87.4 | Adjuvant (A) | 2017-01-11 | 2017-01-15 | Rituximab | N | N | 270023365 | CVP R |
| 270010159 | 270005960 | 0 | null | Curative (C) | 2016-08-03 | 2016-08-03 | NHL 2003 Gp B COP | N | N | 270023375 | CARBOPLATIN + ETOPOSIDE |
| 270010160 | 270005960 | 1.69 | 94 | Palliative (P) | 2015-10-15 | 2015-10-21 | ETOPOSIDE | 2 | N | 270023375 | ECHELON 1 TRIAL |
| 270010161 | 270005961 | 1.7 | 85 | null | null | 2015-11-12 | GEMCITABINE + VINORELBINE | N | N | 270023394 | CVP R |
| 270010162 | 270005961 | 1.79 | 84 | Curative (C) | 2015-10-08 | 2015-10-10 | CAP | Y | N | 270023394 | LOPP |
| 270010163 | 270005962 | null | null | Curative (C) | 2018-02-11 | 2018-02-23 | CHOP - 21 days | N | N | 270023403 | CARBOPLATIN + ETOPOSIDE |
| 270010164 | 270012944 | null | null | null | null | 2015-02-21 | ECHELON 1 TRIAL | null | null | 270023407 | RITUXIMAB |
| 270010165 | 270016087 | 1.7 | 72 | Palliative (P) | 2017-08-31 | 2017-09-09 | Vinblastine | N | N | 270023425 | HYDROXYCARBAMIDE |
| 270010166 | 270017877 | 1.74 | 75.1 | Adjuvant (A) | 2016-01-03 | 2016-01-24 | ECHELON 1 TRIAL | N | N | 270023438 | CVP R |
| 270010167 | 270017877 | 1.6 | 63 | Curative (C) | 2014-04-28 | 2014-05-02 | Bevacizumab + Oxaliplatin +MdG | N | N | 270023438 | IGEV |
| 270010168 | 270017877 | 1.82 | null | Curative (C) | 2017-02-19 | 2017-02-21 | CETUXIMAB + RT | N | N | 270023438 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270010169 | 270005963 | 1.87 | 66.5 | Palliative (P) | 2013-06-30 | 2013-07-12 | COPP | N | N | 270023461 | ETOPOSIDE |
| 270010170 | 270005963 | 1.65 | 69.9 | Curative (C) | 2016-04-15 | 2016-04-26 | ECHELON 1 TRIAL | 01 | N | 270023461 | VINBLASTINE |
| 270010171 | 270005963 | 1.78 | 90 | Curative (C) | 2014-06-07 | 2014-07-01 | SCOT TRIAL | N | N | 270023461 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270010172 | 270005963 | 1.63 | 65.3 | Curative (C) | 2014-05-06 | 2014-05-13 | CHOEP - 21 days | 02 | N | 270023461 | CVP R |
| 270010173 | 270005963 | 1.81 | 66 | Palliative (P) | 2014-04-19 | 2014-04-22 | ECHELON 1 TRIAL | 02 | N | 270023461 | DACARBAZINE |
| 270010174 | 270005964 | 1.45 | 0 | Curative (C) | 2014-07-29 | 2014-08-01 | ABVD R | N | N | 270023505 | CVP R |
| 270010175 | 270005964 | null | 115 | Curative (C) | 2015-02-12 | 2015-02-12 | Rituximab | 02 | N | 270023505 | CHOP |
| 270010176 | 270005964 | null | 79.4 | Not known (9) | 2016-06-05 | 2016-06-16 | ABVD R | N | N | 270023505 | RITUXIMAB |
| 270010177 | 270005965 | 1.8 | 88.5 | Curative (C) | 2018-10-10 | 2018-10-12 | Rituximab | Y | N | 270023525 | ESHAP |
| 270010178 | 270012947 | 1.72 | 54.9 | Curative (C) | 2015-04-10 | 2015-04-11 | ABVD R | N | N | 270023531 | MYELOMA XI TRIAL |
| 270010179 | 270012947 | 1.7 | 70.5 | null | 2015-01-04 | 2015-01-24 | CVP | N | Y | 270023531 | CYTARABINE HIGH DOSE |
| 270010180 | 270005966 | 1.59 | 92.6 | Curative (C) | 2015-12-04 | 2015-12-04 | Rituximab | N | N | 270023548 | VINBLASTINE |
| 270010181 | 270012948 | 1.75 | 74 | Curative (C) | 2014-05-20 | 2014-05-20 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270023554 | TRASTUZUMAB |
| 270010182 | 270012948 | 1.59 | 57.5 | Disease modification (D) | 2015-04-24 | 2015-04-26 | CVP R | Y | N | 270023554 | CAPECITABINE + IRINOTECAN |
| 270010183 | 270012948 | 1.84 | 90 | Curative (C) | 2016-05-09 | 2016-06-06 | Brentuximab | 02 | N | 270023554 | VINBLASTINE |
| 270010184 | 270005967 | 1.85 | 77.6 | Curative (C) | 2017-04-19 | 2017-05-10 | Cyclophosphamide + Etoposide (PO) | 02 | N | 270023573 | CVP R |
| 270010185 | 270005968 | 0 | 51 | Curative (C) | 2016-11-13 | 2016-11-14 | LEAM | 02 | null | 270023574 | GDP |
| 270010186 | 270005969 | 0 | 43 | Palliative (P) | 2013-12-24 | 2014-01-03 | CVP R | Y | N | 270023584 | CVD |
| 270010187 | 270005969 | 1.57 | 59.1 | Curative (C) | 2015-06-09 | 2015-07-01 | NHL 2003 Gp C COPADM 1 | N | N | 270023584 | RITUXIMAB |
| 270010188 | 270005970 | null | 94 | Curative (C) | 2014-01-16 | 2014-01-16 | COPP + Dacarbazine | 2 | N | 270023591 | DHAP |
| 270010189 | 270005971 | 1.8 | 71.9 | Curative (C) | 2017-06-20 | 2017-06-30 | BEAM + Alemtuzumab Allo SCT | 02 | N | 270023595 | LENALIDOMIDE |
| 270010190 | 270005971 | 1.72 | 71 | Curative (C) | 2015-06-27 | 2015-07-02 | Rituximab | N | N | 270023595 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270010191 | 270005971 | 1.74 | 96 | Curative (C) | 2015-04-25 | 2015-05-22 | ALCL ALCL 99 Closed Pre Phase | 02 | N | 270023595 | BRENTUXIMAB |
| 270010192 | 270005972 | null | 53.5 | Palliative (P) | 2013-08-14 | 2013-08-26 | CVP R | 02 | N | 270023624 | BENDAMUSTINE |
| 270010193 | 270005973 | 1.56 | null | Not known (9) | 2013-11-19 | 2013-11-26 | BENDAMUSTINE + RITUXIMAB | 2 | N | 270023626 | ECHELON-1 TRIAL |
| 270010194 | 270005974 | 1.65 | 78.7 | Curative (C) | 2015-05-25 | 2015-06-15 | CETUXIMAB + RT | 02 | N | 270023627 | VINBLASTINE |
| 270010195 | 270005975 | 1.73 | 100 | null | 2017-08-22 | 2017-08-27 | CHOP | N | null | 270023637 | CVP R |
| 270010196 | 270012951 | 2 | 54 | Adjuvant (A) | 2015-04-15 | 2015-04-16 | Hydroxycarbamide | 02 | N | 270023639 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270010197 | 270005976 | 1.77 | 75 | Curative (C) | 2014-03-30 | 2014-03-30 | CVP R | N | N | 270023640 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010198 | 270005977 | 1.7 | 80.9 | Curative (C) | 2016-01-02 | 2016-01-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 270023646 | NOT MATCHED |
| 270010199 | 270005978 | null | 90.8 | Curative (C) | 2016-05-26 | 2016-06-24 | CTD | null | Y | 270023649 | RITUXIMAB |
| 270010200 | 270012952 | 1.7 | null | Curative (C) | 2015-08-24 | 2015-09-10 | BEAM + FLUDARABINE | 02 | N | 270023650 | NOT MATCHED |
| 270010201 | 270016093 | 1.84 | null | Disease modification (D) | 2013-07-31 | 2013-08-08 | CVP R | 2 | N | 270023657 | VINBLASTINE |
| 270010202 | 270017880 | 1.77 | 52.8 | Adjuvant (A) | 2014-07-29 | 2014-07-29 | Rituximab | N | null | 270023661 | ECHELON-2 TRIAL |
| 270010203 | 270018907 | 1.75 | 95.4 | Curative (C) | 2015-04-29 | 2015-05-21 | CVP R | N | N | 270023671 | ECHELON 1 TRIAL |
| 270010204 | 270005979 | 1.55 | 51 | Curative (C) | 2015-11-16 | 2015-12-02 | Vinblastine | 02 | N | 270023675 | BRENTUXIMAB |
| 270010205 | 270005980 | 1.72 | 48.6 | null | null | 2017-04-13 | null | null | null | 270023690 | NOT MATCHED |
| 270010206 | 270012953 | 1.74 | 87 | Curative (C) | null | 2014-08-30 | ECHELON 1 TRIAL | null | null | 270023696 | VINBLASTINE |